Transgenic Group (TSE:2342) OCF Margin %: 8.56% (As of Mar. 2026) — 607% Above Median

What is Transgenic Group OCF Margin %?

Transgenic Group TSE:2342 -0.96% 54 OCF Margin % is 8.56% as of Mar. 2026, which is 607% above its 10-year median of 1.21. GuruFocus rates TSE:2342 with a GF Score™ of 54/100 and a GF Value™ of 円257.18 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Transgenic Group ranks better than 68.51% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Transgenic Group's Cash Flow from Operations for the six months ended in Mar. 2026 was 円595 Mil. Transgenic Group's Revenue for the six months ended in Mar. 2026 was 円6,950 Mil. Therefore, Transgenic Group's OCF Margin % for the quarter that ended in Mar. 2026 was 8.56%.

As of today, Transgenic Group's current OCF Yield % is 0.75%.

The historical rank and industry rank for Transgenic Group's OCF Margin % or its related term are showing as below:

TSE:2342' s OCF Margin % Range Over the Past 10 Years
Min: -12.51 Med: 1.21 Max: 14.23
Current: 0.2

During the past 13 years, the highest OCF Margin % of Transgenic Group was 14.23%. The lowest was -12.51%. And the median was 1.21%.

TSE:2342's OCF Margin % is ranked better than
68.51% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs TSE:2342: 0.20

Transgenic Group OCF Margin % Related Terms

Transgenic Group OCF Margin % Historical Data

* Premium members only.

The historical data trend for Transgenic Group's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group OCF Margin % Chart

Transgenic Group Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

OCF Margin %

Get a 7-Day Free Trial

14.23

-12.51

-3.00

0.72

0.20

Transgenic Group Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-0.40	-6.67	7.70	-9.14	8.56

TSE:2342 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Transgenic Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transgenic Group OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Transgenic Group's OCF Margin % falls into.

Save Embed

54GF Score

Transgenic Group Inc TSE:2342

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Transgenic Group OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Transgenic Group's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Mar. 2026 )	/	Revenue (A: Mar. 2026 )
	=	25.91	/	13174.425
	=	0.20 %

Transgenic Group's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	594.697	/	6949.572
	=	8.56 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of 8.56% mean?

Transgenic Group (TSE:2342) has a OCF Margin % of 8.56% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Transgenic Group and its competitors. This is 607% above median its historical median of 1.21. According to the industry distribution chart, Transgenic Group ranks #302 out of 959 companies in the Biotechnology industry, placing it in the top 31.5%.

Is Transgenic Group's OCF Margin % too high?

Transgenic Group's current OCF Margin % of 8.56% is 607% above median its 10-year median of 1.21. Based on the distribution chart, Transgenic Group ranks #302 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Transgenic Group has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Transgenic Group's OCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Transgenic Group ranks #302 out of 959 companies for OCF Margin %. This puts Transgenic Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Transgenic Group and its competitors. Transgenic Group's current OCF Margin % is 8.56%, which is 607% above median its own 10-year median of 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Transgenic Group stock overvalued right now?

Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.18, compared to a current price of 円207.00 — trading 19.5% below its estimated fair value. The current OCF Margin % is 8.56%, which is 607% above median its 10-year median of 1.21. Transgenic Group's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current OCF Margin % is 8.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円207.00 is trading 19.5% below its estimated GF Value™ of 円257.18. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

OCF Margin %: 8.56% (607% above median its 10-year median of 1.21)
GF Value™: 円257.18 vs. price of 円207.00 (19.5% below fair value)
GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgenic Group Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:4576 TSE:4591 TSE:2183 TSE:4884 TSE:177A TSE:206A TSE:130A TSE:4881 TSE:4893 TSE:4891 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN

Website https://www.transgenic.co.jp

Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.

54GF Score

Get the complete analysis for TSE:2342

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円207.00

Price

円257.18

GF Value

View TSE:2342 Analysis

See OCF Margin % data for all stocks →